Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer

By Sørbye Halfdan   Berglund Åke   Tveit Kjell Magne   Øgreid Dagfinn   Wanderås Eva Hoff   Wentzel-Larsen Tore   Dahl Olav   Glimelius Bengt  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 982-988

Informa Healthcare

Access to resources Recommend Favorite

First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status

By                

Experimental and Therapeutic Medicine, Vol. 4, Iss. 4, 2012-01 ,pp. : 562-568

Spandidos Publications

Access to resources Recommend Favorite

Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer

By Argyriou Andreas   Polychronopoulos Panagiotis   Iconomou Gregoris   Koutras Angelos   Makatsoris Thomas   Gerolymos Miltiadis   Gourzis Philippos   Assimakopoulos Konstantinos   Kalofonos Haralabos   Chroni Elisabeth  

Acta Oncologica, Vol. 46, Iss. 8, 2007-01 ,pp. : 1131-1137

Informa Healthcare

Access to resources Recommend Favorite

Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: A multicenter non-randomized phase II study

By Santini Daniele   Massacesi Cristian   D’Angelillo Rolando   Marcucci Fabiana   Campisi Costantino   Vincenzi Bruno   Pilone Alberta   Bianco Vincenzo   Bonsignori Maurizio   Tonini Giuseppe  

Medical Oncology, Vol. 21, Iss. 1, 2004-03 ,pp. : 59-66

Humana Press, Inc

Access to resources Recommend Favorite

Oxaliplatin-based chemotherapy for the treatment of a metastatic carcinoid tumor

By Tetzlaff Eric   Ajani Jaffer  

International Journal of Gastrointestinal Cancer, Vol. 36, Iss. 1, 2005-08 ,pp. : 55-58

Humana Press, Inc

Access to resources Recommend Favorite